Cognition Therapeutics reported net income of -$3.93M for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.61M | 5.19M | 22.58M | 22.60M | 23.97M | 23.64M | 29.28M | 30.29M | 30.42M | 32.17M | 39.99M | 40.11M | 40.81M | 39.73M | 61.97M | 64.96M | 88.27M | 72.77M | 89.35M | 95.06M | ||||
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 3.67M | 6.52M | 8.27M | 5.43M | 8.50M | 11.67M | 11.60M | 10.55M | 11.58M | 11.39M | 8.15M | 10.79M | 11.48M | 3.77M | 11.15M | 6.12M | 5.10M | |||||||
| Selling, General & AdministrativeSG&A | 1.55M | 2.90M | 4.36M | 3.54M | 3.32M | 3.08M | 3.59M | 3.55M | 3.10M | 3.07M | 2.57M | 2.99M | 2.50M | 2.60M | 2.52M | 2.70M | 2.64M | |||||||
| Operating ExpensesOpex | 5.22M | 9.41M | 12.62M | 8.97M | 11.82M | 14.74M | 15.19M | 14.10M | 14.68M | 14.46M | 10.72M | 13.78M | 13.98M | 6.38M | 13.67M | 8.82M | 7.74M | |||||||
| Operating IncomeOp. Inc | -5.22M | -11.81M | -9.41M | -12.62M | -12.21M | -8.97M | -11.82M | -14.74M | -15.19M | -14.10M | -14.68M | -14.46M | -10.72M | -13.78M | -13.98M | -6.38M | -13.67M | -8.82M | -7.74M | |||||
| EBIT | -5.22M | -11.81M | -9.41M | -5.88M | -12.62M | -12.21M | -8.97M | -11.82M | -14.74M | -15.19M | -14.10M | -14.68M | -14.46M | -10.72M | -13.78M | -13.98M | -6.38M | -13.67M | -8.82M | -7.74M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.01M | -0.00M | -0.01M | -0.01M | -0.01M | -0.00M | -0.01M | -0.01M | -0.00M | -0.01M | -0.01M | -0.00M | ||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 2.11M | 4.47M | 5.70M | 6.00M | 6.34M | 2.80M | 7.09M | 8.00M | 7.05M | 4.95M | 7.64M | 4.53M | 2.88M | 5.29M | 7.24M | 1.45M | 10.33M | 4.25M | 3.81M | |||||
| Net income details | ||||||||||||||||||||||||
| EBT | -5.22M | -11.81M | -3.71M | -5.88M | -12.62M | -12.21M | -6.17M | -4.73M | -14.75M | -15.20M | -14.11M | -14.69M | -14.47M | -10.73M | -13.78M | -13.98M | -6.38M | -13.68M | -8.82M | -7.74M | ||||
| Tax ProvisionsTaxes | 0.12M | -0.12M | ||||||||||||||||||||||
| Profit After TaxPAT | -3.11M | -7.34M | -3.84M | -5.75M | -6.63M | -5.18M | -6.17M | -4.73M | -6.75M | -8.14M | -9.15M | -7.04M | -9.94M | -7.84M | -8.48M | -6.73M | -4.93M | -3.34M | -4.57M | -3.93M | ||||
| Income from Continuing OperationsIncome (Continuing) | -5.22M | -11.81M | -3.84M | -5.75M | -12.62M | -12.21M | -6.17M | -4.73M | -14.75M | -15.20M | -14.11M | -14.69M | -14.47M | -10.73M | -13.78M | -13.98M | -6.38M | -13.68M | -8.82M | -7.74M | ||||
| Consolidated Net IncomeConsol Net Inc. | -5.22M | -11.81M | -3.84M | -5.75M | -12.62M | -12.21M | -6.17M | -4.73M | -14.75M | -15.20M | -14.11M | -14.69M | -14.47M | -10.73M | -13.78M | -13.98M | -6.38M | -13.68M | -8.82M | -7.74M | ||||
| Income towards Parent CompanyParent Net Inc | -5.22M | -11.81M | -3.84M | -5.75M | -12.62M | -12.21M | -6.17M | -4.73M | -14.75M | -15.20M | -14.11M | -14.69M | -14.47M | -10.73M | -13.78M | -13.98M | -6.38M | -13.68M | -8.82M | -7.74M | ||||
| Preferred Dividend PaymentsPref Dividends | 1.86M | |||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -4.97M | -11.81M | -3.84M | -5.75M | -6.62M | -12.21M | -6.17M | -4.73M | -14.75M | -15.20M | -14.11M | -14.69M | -14.47M | -10.73M | -13.78M | -13.98M | -6.38M | -13.68M | -8.82M | -7.74M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -8.12 | -2.27 | -0.17 | -0.25 | -0.29 | -0.52 | -0.21 | -0.16 | -0.49 | -0.51 | -0.42 | -0.37 | -0.36 | -0.27 | -0.22 | -0.22 | -0.08 | -0.19 | -0.10 | -0.09 | ||||
| EPS (Diluted) | -8.12 | -2.27 | -0.17 | -0.25 | -0.29 | -0.52 | -0.21 | -0.16 | -0.49 | -0.51 | -0.42 | -0.37 | -0.36 | -0.27 | -0.22 | -0.22 | -0.08 | -0.19 | -0.10 | -0.09 | ||||
| Shares Outstanding | 0.61M | 5.19M | 22.43M | 22.60M | 23.02M | 23.64M | 29.09M | 29.61M | 30.37M | 30.03M | 33.74M | 40.06M | 40.42M | 39.73M | 61.83M | 63.69M | 77.95M | 72.77M | 89.19M | 90.62M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.61M | 5.19M | 22.43M | 22.60M | 23.02M | 23.64M | 29.09M | 29.61M | 30.37M | 30.03M | 33.74M | 40.06M | 40.42M | 39.73M | 61.83M | 63.69M | 77.95M | 72.77M | 89.19M | 90.62M | ||||
| EBITDA | -5.22M | -11.81M | -9.41M | -5.88M | -12.62M | -12.21M | -8.97M | -11.82M | -14.74M | -15.19M | -14.10M | -14.68M | -14.46M | -10.72M | -13.78M | -13.98M | -6.38M | -13.67M | -8.82M | -7.74M | ||||
| Tax Rate | -3.37 | 2.13 |